Bariatric Surgery and Long-term Durability of Weight Loss | Bariatric Surgery | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Buchwald  H, Avidor  Y, Braunwald  E,  et al.  Bariatric surgery: a systematic review and meta-analysis.  JAMA. 2004;292(14):1724-1737.PubMedGoogle ScholarCrossref
2.
Picot  J, Jones  J, Colquitt  JL,  et al.  The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.  Health Technol Assess. 2009;13(41):1-190, 215-357, iii-iv.PubMedGoogle ScholarCrossref
3.
Gloy  VL, Briel  M, Bhatt  DL,  et al.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.  BMJ. 2013;347:f5934.PubMedGoogle ScholarCrossref
4.
Arterburn  DE, Courcoulas  AP.  Bariatric surgery for obesity and metabolic conditions in adults.  BMJ. 2014;349:g3961.PubMedGoogle ScholarCrossref
5.
Trastulli  S, Desiderio  J, Guarino  S,  et al.  Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials.  Surg Obes Relat Dis. 2013;9(5):816-829.PubMedGoogle ScholarCrossref
6.
Ikramuddin  S, Blackstone  RP, Brancatisano  A,  et al.  Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.  JAMA. 2014;312(9):915-922.PubMedGoogle ScholarCrossref
7.
Mingrone  G, Panunzi  S, De Gaetano  A,  et al.  Bariatric surgery versus conventional medical therapy for type 2 diabetes.  N Engl J Med. 2012;366(17):1577-1585.PubMedGoogle ScholarCrossref
8.
Schauer  PR, Kashyap  SR, Wolski  K,  et al.  Bariatric surgery versus intensive medical therapy in obese patients with diabetes.  N Engl J Med. 2012;366(17):1567-1576.PubMedGoogle ScholarCrossref
9.
Schauer  PR, Bhatt  DL, Kirwan  JP,  et al; STAMPEDE Investigators.  Bariatric surgery versus intensive medical therapy for diabetes: 3-year outcomes.  N Engl J Med. 2014;370(21):2002-2013.PubMedGoogle ScholarCrossref
10.
Halperin  F, Ding  SA, Simonson  DC,  et al.  Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.  JAMA Surg. 2014;149(7):716-726.PubMedGoogle ScholarCrossref
11.
Courcoulas  AP, Goodpaster  BH, Eagleton  JK,  et al.  Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial.  JAMA Surg. 2014;149(7):707-715.PubMedGoogle ScholarCrossref
12.
Courcoulas  AP, Belle  SH, Neiberg  RH,  et al.  Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial.  JAMA Surg. 2015;150(10):931-940.PubMedGoogle ScholarCrossref
13.
Courcoulas  AP, Christian  NJ, Belle  SH,  et al; Longitudinal Assessment of Bariatric Surgery (LABS) Consortium.  Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity.  JAMA. 2013;310(22):2416-2425.PubMedGoogle Scholar
14.
Mingrone  G, Panunzi  S, De Gaetano  A,  et al.  Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.  Lancet. 2015;386(9997):964-973.PubMedGoogle ScholarCrossref
15.
Ikramuddin  S, Korner  J, Lee  WJ,  et al.  Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.  JAMA. 2013;309(21):2240-2249.PubMedGoogle ScholarCrossref
16.
Arterburn  D, Powers  JD, Toh  S,  et al.  Comparative effectiveness of laparoscopic adjustable gastric banding vs laparoscopic gastric bypass.  JAMA Surg. 2014;149(12):1279-1287.PubMedGoogle ScholarCrossref
17.
Hutter  MM, Schirmer  BD, Jones  DB,  et al.  First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass.  Ann Surg. 2011;254(3):410-420.PubMedGoogle ScholarCrossref
18.
Carlin  AM, Zeni  TM, English  WJ,  et al; Michigan Bariatric Surgery Collaborative.  The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity.  Ann Surg. 2013;257(5):791-797.PubMedGoogle ScholarCrossref
19.
Sjöström  L, Lindroos  AK, Peltonen  M,  et al; Swedish Obese Subjects Study Scientific Group.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.  N Engl J Med. 2004;351(26):2683-2693.PubMedGoogle ScholarCrossref
20.
Puzziferri  N, Roshek  TB  III, Mayo  HG, Gallagher  R, Belle  SH, Livingston  EH.  Long-term follow-up after bariatric surgery: a systematic review.  JAMA. 2014;312(9):934-942.PubMedGoogle ScholarCrossref
21.
Adams  TD, Davidson  LE, Litwin  SE,  et al.  Health benefits of gastric bypass surgery after 6 years.  JAMA. 2012;308(11):1122-1131.PubMedGoogle ScholarCrossref
22.
O’Brien  PE, Brennan  L, Laurie  C, Brown  W.  Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomised trial.  Obes Surg. 2013;23(9):1345-1353.PubMedGoogle ScholarCrossref
23.
Arterburn  DE, Olsen  MK, Smith  VA,  et al.  Association between bariatric surgery and long-term survival.  JAMA. 2015;313(1):62-70.PubMedGoogle ScholarCrossref
24.
Angrisani  L, Santonicola  A, Iovino  P, Formisano  G, Buchwald  H, Scopinaro  N.  Bariatric Surgery Worldwide 2013.  Obes Surg. 2015;25(10):1822-1832.PubMedGoogle ScholarCrossref
25.
Ponce  J, Nguyen  NT, Hutter  M, Sudan  R, Morton  JM.  American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011-2014.  Surg Obes Relat Dis. 2015;11(6):1199-1200.PubMedGoogle ScholarCrossref
26.
Kennedy  EH, Taylor  JM, Schaubel  DE, Williams  S.  The effect of salvage therapy on survival in a longitudinal study with treatment by indication.  Stat Med. 2010;29(25):2569-2580.PubMedGoogle ScholarCrossref
27.
Li  YP, Propert  KJ, Rosenbaum  PR.  Balanced risk set matching.  J Am Stat Assoc. 2001;96(455):870-882.Google ScholarCrossref
28.
Lu  B.  Propensity score matching with time-dependent covariates.  Biometrics. 2005;61(3):721-728.PubMedGoogle ScholarCrossref
29.
Gu  XS, Rosenbaum  PR.  Comparison of multivariate matching methods: structures, distances and algorithms.  J Comput Graph Stat. 1993;2(4):405-420.Google Scholar
30.
Hatoum  IJ, Kaplan  LM.  Advantages of percent weight loss as a method of reporting weight loss after Roux-en-Y gastric bypass.  Obesity (Silver Spring). 2013;21(8):1519-1525.PubMedGoogle ScholarCrossref
31.
Fitzmaurice  GL, Laird  NM, Ware  JH.  Applied Longitudinal Analysis. New York, NY: Wiley; 2004.
32.
Durbán  M, Harezlak  J, Wand  MP, Carroll  RJ.  Simple fitting of subject-specific curves for longitudinal data.  Stat Med. 2005;24(8):1153-1167.PubMedGoogle ScholarCrossref
33.
Hsu  C, Liss  DT, Westbrook  EO, Arterburn  D.  Incorporating patient decision aids into standard clinical practice in an integrated delivery system.  Med Decis Making. 2013;33(1):85-97.PubMedGoogle ScholarCrossref
34.
Wee  CC, Jones  DB, Davis  RB, Bourland  AC, Hamel  MB.  Understanding patients’ value of weight loss and expectations for bariatric surgery.  Obes Surg. 2006;16(4):496-500.PubMedGoogle ScholarCrossref
35.
Kaly  P, Orellana  S, Torrella  T, Takagishi  C, Saff-Koche  L, Murr  MM.  Unrealistic weight loss expectations in candidates for bariatric surgery.  Surg Obes Relat Dis. 2008;4(1):6-10.PubMedGoogle ScholarCrossref
36.
Heinberg  LJ, Keating  K, Simonelli  L.  Discrepancy between ideal and realistic goal weights in three bariatric procedures: who is likely to be unrealistic?  Obes Surg. 2010;20(2):148-153.PubMedGoogle ScholarCrossref
37.
Kahwati  LC, Lance  TX, Jones  KR, Kinsinger  LS.  RE-AIM evaluation of the Veterans Health Administration’s MOVE! Weight Management Program.  Transl Behav Med. 2011;1(4):551-560.PubMedGoogle ScholarCrossref
38.
Coleman  KJ, Huang  YC, Hendee  F, Watson  HL, Casillas  RA, Brookey  J.  Three-year weight outcomes from a bariatric surgery registry in a large integrated healthcare system.  Surg Obes Relat Dis. 2014;10(3):396-403.PubMedGoogle ScholarCrossref
Original Investigation
November 2016

Bariatric Surgery and Long-term Durability of Weight Loss

Author Affiliations
  • 1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, North Carolina
  • 2Division of General Internal Medicine, Department of Medicine, Duke University, Durham, North Carolina
  • 3Group Health Research Institute, Seattle, Washington
  • 4Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle
  • 5Veterans Administration North Texas Health Care System, Dallas, Texas
  • 6Division of Gastrointestinal and Endocrine Surgery, University of Texas Southwestern Medical Center, Dallas
  • 7Division of General Surgery, Northwestern University, Chicago, Illinois
  • 8Deputy Editor, JAMA
  • 9Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina
JAMA Surg. 2016;151(11):1046-1055. doi:10.1001/jamasurg.2016.2317
Key Points

Questions  How much weight loss can be expected on average 10 years after undergoing Roux-en-Y gastric bypass (RYGB) and how does weight loss 4 years after bariatric surgery compare among patients undergoing RYGB, adjustable gastric banding, and sleeve gastrectomy?

Findings  In this cohort study, patients undergoing RYGB lost 21% more of their baseline weight than matched nonsurgical patients at 10 years, and RYGB induced significantly greater weight loss than sleeve gastrectomy or adjustable gastric banding at 4 years.

Meaning  Bariatric surgery, especially RYGB, is effective at promoting long-term weight loss among obese patients.

Abstract

Importance  Bariatric surgery induces significant weight loss for severely obese patients, but there is limited evidence of the durability of weight loss compared with nonsurgical matches and across bariatric procedures.

Objectives  To examine 10-year weight change in a large, multisite, clinical cohort of veterans who underwent Roux-en-Y gastric bypass (RYGB) compared with nonsurgical matches and the 4-year weight change in veterans who underwent RYGB, adjustable gastric banding (AGB), or sleeve gastrectomy (SG).

Design, Setting, and Participants  In this cohort study, differences in weight change up to 10 years after surgery were estimated in retrospective cohorts of 1787 veterans who underwent RYGB from January 1, 2000, through September 30, 2011 (573 of 700 eligible [81.9%] with 10-year follow-up), and 5305 nonsurgical matches (1274 of 1889 eligible [67.4%] with 10-year follow-up) in mixed-effects models. Differences in weight change up to 4 years were compared among veterans undergoing RYGB (n = 1785), SG (n = 379), and AGB (n = 246). Data analysis was performed from September 9, 2014, to February 12, 2016.

Exposures  Bariatric surgical procedures and usual care.

Main Outcomes and Measures  Weight change up to 10 years after surgery through December 31, 2014.

Results  The 1787 patients undergoing RYGB had a mean (SD) age of 52.1 (8.5) years and 5305 nonsurgical matches had a mean (SD) age of 52.2 (8.4) years. Patients undergoing RYGB and nonsurgical matches had a mean body mass index of 47.7 and 47.1, respectively, and were predominantly male (1306 [73.1%] and 3911 [73.7%], respectively). Patients undergoing RYGB lost 21% (95% CI, 11%-31%) more of their baseline weight at 10 years than nonsurgical matches. A total of 405 of 564 patients undergoing RYGB (71.8%) had more than 20% estimated weight loss, and 224 of 564 (39.7%) had more than 30% estimated weight loss at 10 years compared with 134 of 1247 (10.8%) and 48 of 1247 (3.9%), respectively, of nonsurgical matches. Only 19 of 564 patients undergoing RYGB (3.4%) regained weight back to within an estimated 5% of their baseline weight by 10 years. At 4 years, patients undergoing RYGB lost 27.5% (95% CI, 23.8%-31.2%) of their baseline weight, patients undergoing AGB lost 10.6% (95% CI, 0.6%-20.6%), and patients undergoing SG lost 17.8% (95% CI, 9.7%-25.9%). Patients undergoing RYGB lost 16.9% (95% CI, 6.2%-27.6%) more of their baseline weight than patients undergoing AGB and 9.7% (95% CI, 0.8%-18.6%) more than patients undergoing SG.

Conclusions and Relevance  Patients in the Veterans Administration health care system lost substantially more weight than nonsurgical matches and sustained most of this weight loss in the long term. Roux-en-Y gastric bypass induced significantly greater weight loss among veterans than SG or AGB at 4 years. These results provide further evidence of the beneficial association between surgery and long-term weight loss that has been demonstrated in shorter-term studies of younger, predominantly female populations.

×